VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-81043
Recombinant Monoclonal Antibody
![Immunocytochemistry/ Immunofluorescence: VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free [NBP2-81043]](https://resources.bio-techne.com/images/products/VAP-1-AOC3-Antibody-TK8-14-Chimeric-Immunocytochemistry-Immunofluorescence-NBP2-81043-img0001.jpg "Immunocytochemistry/ Immunofluorescence: VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free [NBP2-81043]")
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Kappa Clone # TK8-14
Format
Azide and BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Affinity purified VAP-1/AOC3 from tonsil stroma of human origin.
Specificity
Recognises human Vascular Adhesion Protein-1 (VAP-1/AOC3), a glycosylated homodimeric membrane protein consisting of two 90 kDa subunits connected by disulfide bonds. Epitope recognized by TK8-18 is present both in dimeric and monomeric forms of VAP-1/AOC3. Elevated soluble VAP-1/AOC3 serum- levels have been described in several inflammatory- diseases as well as colorectal cancer. TK8-14 is a function-blocking mAb.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Scientific Data Images for VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free
Immunocytochemistry/ Immunofluorescence: VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free [NBP2-81043]
Immunocytochemistry/Immunofluorescence: VAP-1/AOC3 Antibody (TK8-14) - Chimeric [NBP2-81043] - Immunofluoresence staining of HeLa cells with anti-VAP-1 antibody (TK8-14). Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton and stained with the chimeric rabbit version of TK8-14 [NBP2-81043] at 10ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81043, DAPI, merged channels and a negative control. The negative control was stained with unimmunized rabbit IgG followed by Alexa Fluor 488 secondary antibody.Applications for VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
Azide and BSA Free
Preservative
0.02% Proclin 300
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C for up to 3 months. For longer storage, aliquot and store at -20C.
Background: VAP-1/AOC3
Long Name
Vascular Adhesion Protein-1
Alternate Names
AOC3, HPAO, SSAO, VAP1
Gene Symbol
AOC3
Additional VAP-1/AOC3 Products
Product Documents for VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free
Product Specific Notices for VAP-1/AOC3 Antibody (TK8-14) - Chimeric - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...